Enhancement of androgen action in the kidneys of transgenic mice harboring the mutant human UMOD gene

Yuichi Takiue, Makoto Hosoyamada, Masaki Kimura, Hidetsugu Saito

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Uromodulin storage diseases are characterized by hyperuricemia of underexcretion type and renal insufficiency. Although these diseases are caused by mutations in the UMOD gene that encodes the kidney-specific glycoprotein uromodulin, the effect of uromodulin mutation on the kidney has not been clearly established. In this study, we investigated the effect by comparing transgenic mice expressing human uromodulin with and without mutation. Change in the intracellular localization of human uromodulin protein was shown in the kidney of transgenic mice expressing mutant human uromodulin by a deglycosylation experiment. Then, we determined by microarray technology and quantitative real-time PCR that the strongly induced gene in the kidney of these mice was 5-α-reductase 2, an enzyme that converts testosterone into the more potent androgen. Moreover, the expressions of androgen-induced genes β-glucuronidase, ornithine decarboxylase structural 1, and cytochrome P450 4a12a were increased. The increase in mRNA levels of urate reabsorptive transport system urate transporter 1 could be investigated, but the changes in its protein level and renal urate handling could not be demonstrated. Therefore, it is suggested that a uromodulin mutation may be responsible for the enhancement of renal androgen action.

Original languageEnglish
Pages (from-to)383-389
Number of pages7
JournalJournal of Pharmacological Sciences
Volume115
Issue number3
DOIs
Publication statusPublished - 2011

Fingerprint

Uromodulin
Transgenic Mice
Androgens
Kidney
Genes
Mutation
Uric Acid
Hyperuricemia
Ornithine Decarboxylase
Glucuronidase
Cytochrome P-450 Enzyme System
Renal Insufficiency
Testosterone
Real-Time Polymerase Chain Reaction
Glycoproteins
Oxidoreductases
Technology
Messenger RNA
Enzymes
Proteins

Keywords

  • Androgen
  • Kidney
  • Transgenic mice
  • Urate transport system
  • Uromodulin

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Enhancement of androgen action in the kidneys of transgenic mice harboring the mutant human UMOD gene. / Takiue, Yuichi; Hosoyamada, Makoto; Kimura, Masaki; Saito, Hidetsugu.

In: Journal of Pharmacological Sciences, Vol. 115, No. 3, 2011, p. 383-389.

Research output: Contribution to journalArticle

@article{a10d8304dd53423d8ccf7d4f4a1f7105,
title = "Enhancement of androgen action in the kidneys of transgenic mice harboring the mutant human UMOD gene",
abstract = "Uromodulin storage diseases are characterized by hyperuricemia of underexcretion type and renal insufficiency. Although these diseases are caused by mutations in the UMOD gene that encodes the kidney-specific glycoprotein uromodulin, the effect of uromodulin mutation on the kidney has not been clearly established. In this study, we investigated the effect by comparing transgenic mice expressing human uromodulin with and without mutation. Change in the intracellular localization of human uromodulin protein was shown in the kidney of transgenic mice expressing mutant human uromodulin by a deglycosylation experiment. Then, we determined by microarray technology and quantitative real-time PCR that the strongly induced gene in the kidney of these mice was 5-α-reductase 2, an enzyme that converts testosterone into the more potent androgen. Moreover, the expressions of androgen-induced genes β-glucuronidase, ornithine decarboxylase structural 1, and cytochrome P450 4a12a were increased. The increase in mRNA levels of urate reabsorptive transport system urate transporter 1 could be investigated, but the changes in its protein level and renal urate handling could not be demonstrated. Therefore, it is suggested that a uromodulin mutation may be responsible for the enhancement of renal androgen action.",
keywords = "Androgen, Kidney, Transgenic mice, Urate transport system, Uromodulin",
author = "Yuichi Takiue and Makoto Hosoyamada and Masaki Kimura and Hidetsugu Saito",
year = "2011",
doi = "10.1254/jphs.10240FP",
language = "English",
volume = "115",
pages = "383--389",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8613",
publisher = "Japanese Pharmacological Society",
number = "3",

}

TY - JOUR

T1 - Enhancement of androgen action in the kidneys of transgenic mice harboring the mutant human UMOD gene

AU - Takiue, Yuichi

AU - Hosoyamada, Makoto

AU - Kimura, Masaki

AU - Saito, Hidetsugu

PY - 2011

Y1 - 2011

N2 - Uromodulin storage diseases are characterized by hyperuricemia of underexcretion type and renal insufficiency. Although these diseases are caused by mutations in the UMOD gene that encodes the kidney-specific glycoprotein uromodulin, the effect of uromodulin mutation on the kidney has not been clearly established. In this study, we investigated the effect by comparing transgenic mice expressing human uromodulin with and without mutation. Change in the intracellular localization of human uromodulin protein was shown in the kidney of transgenic mice expressing mutant human uromodulin by a deglycosylation experiment. Then, we determined by microarray technology and quantitative real-time PCR that the strongly induced gene in the kidney of these mice was 5-α-reductase 2, an enzyme that converts testosterone into the more potent androgen. Moreover, the expressions of androgen-induced genes β-glucuronidase, ornithine decarboxylase structural 1, and cytochrome P450 4a12a were increased. The increase in mRNA levels of urate reabsorptive transport system urate transporter 1 could be investigated, but the changes in its protein level and renal urate handling could not be demonstrated. Therefore, it is suggested that a uromodulin mutation may be responsible for the enhancement of renal androgen action.

AB - Uromodulin storage diseases are characterized by hyperuricemia of underexcretion type and renal insufficiency. Although these diseases are caused by mutations in the UMOD gene that encodes the kidney-specific glycoprotein uromodulin, the effect of uromodulin mutation on the kidney has not been clearly established. In this study, we investigated the effect by comparing transgenic mice expressing human uromodulin with and without mutation. Change in the intracellular localization of human uromodulin protein was shown in the kidney of transgenic mice expressing mutant human uromodulin by a deglycosylation experiment. Then, we determined by microarray technology and quantitative real-time PCR that the strongly induced gene in the kidney of these mice was 5-α-reductase 2, an enzyme that converts testosterone into the more potent androgen. Moreover, the expressions of androgen-induced genes β-glucuronidase, ornithine decarboxylase structural 1, and cytochrome P450 4a12a were increased. The increase in mRNA levels of urate reabsorptive transport system urate transporter 1 could be investigated, but the changes in its protein level and renal urate handling could not be demonstrated. Therefore, it is suggested that a uromodulin mutation may be responsible for the enhancement of renal androgen action.

KW - Androgen

KW - Kidney

KW - Transgenic mice

KW - Urate transport system

KW - Uromodulin

UR - http://www.scopus.com/inward/record.url?scp=79952795323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952795323&partnerID=8YFLogxK

U2 - 10.1254/jphs.10240FP

DO - 10.1254/jphs.10240FP

M3 - Article

C2 - 21358122

AN - SCOPUS:79952795323

VL - 115

SP - 383

EP - 389

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8613

IS - 3

ER -